title: From mole to scar: the unintended consequence of treatment with an over-the-counter mole removal cream.
abstract: A 26-year-old man presented with a scar at the site of a pigmented lesion treated with DermaTend (Solace Interntational, Inc., Reno, NV), an over-the-counter mole removal cream. According to the patient, the pigmented lesion had been present since childhood, was asymptomatic, and had not changed in appearance. It remained cosmetically displeasing to him. In an effort to remove the lesion, he had applied DermaTend on a daily basis for several weeks, at which point he noticed a scar at the site of treatment.
authors: Department of Dermatology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA. tarabronsnick@gmail.com
authors: Tara
authors: T
authors: Bronsnick
authors: Department of Dermatology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
authors: A Yasmine
authors: AY
authors: Kirkorian
authors: Department of Dermatology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
authors: Irfan
authors: I
authors: Khan
authors: Rutgers University, New Brunswick, NJ, USA.
authors: Allison
authors: A
authors: Cole
authors: Department of Dermatology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
authors: Babar K
authors: BK
authors: Rao
mesh_terms: D000328:Adult; D002921:Cicatrix / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D008297:Male; D009506:Nevus / Q000188:drug therapy*; D004366:Nonprescription Drugs / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D004366:Nonprescription Drugs